Literature DB >> 24414113

Highly sensitive pyrogen detection on medical devices by the monocyte activation test.

Katharina Stang1, Stefan Fennrich, Stefanie Krajewski, Sandra Stoppelkamp, Iwan Anton Burgener, Hans-Peter Wendel, Marcell Post.   

Abstract

Pyrogens are components of microorganisms, like bacteria, viruses or fungi, which can induce a complex inflammatory response in the human body. Pyrogen contamination on medical devices prior operation is still critical and associated with severe complications for the patients. The aim of our study was to develop a reliable test, which allows detection of pyrogen contamination on the surface of medical devices. After in vitro pyrogen contamination of different medical devices and incubation in a rotation model, the human whole blood monocyte activation test (MAT), which is based on an IL-1β-specific ELISA, was employed. Our results show that when combining a modified MAT protocol and a dynamic incubation system, even smallest amounts of pyrogens can be directly detected on the surface of medical devices. Therefore, screening of medical devices prior clinical application using our novel assay, has the potential to significantly reduce complications associated with pyrogen-contaminated medical devices.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24414113     DOI: 10.1007/s10856-013-5136-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  32 in total

Review 1.  A new era in pyrogen testing.

Authors:  J L Ding; B Ho
Journal:  Trends Biotechnol       Date:  2001-08       Impact factor: 19.536

2.  THE ROLE OF ENDOTOXIN IN THE EXTRACELLULAR COAGULATION OF LIMULUS BLOOD.

Authors:  J LEVIN; F B BANG
Journal:  Bull Johns Hopkins Hosp       Date:  1964-09

3.  Fever from pathogenic fungi.

Authors:  A I BRAUDE; J McCONNELL; H DOUGLAS
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

4.  New Applications of the Human Whole Blood Pyrogen Assay (PyroCheck).

Authors: 
Journal:  ALTEX       Date:  1999       Impact factor: 6.043

5.  Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin.

Authors:  S E Greisman; R B Hornick
Journal:  Proc Soc Exp Biol Med       Date:  1969-09

6.  In vitro pyrogen test--A new test method for solid medical devices.

Authors:  Francesca Mazzotti; Julia Beuttler; Richard Zeller; Ulrich Fink; Stefanie Schindler; Albrecht Wendel; Thomas Hartung; Sonja von Aulock
Journal:  J Biomed Mater Res A       Date:  2007-02       Impact factor: 4.396

7.  Endotoxin-like properties of the peptidoglycan.

Authors:  J Rotta
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

8.  Cytotoxicity and induction of proinflammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor and indoor air.

Authors:  C Monn; S Becker
Journal:  Toxicol Appl Pharmacol       Date:  1999-03-15       Impact factor: 4.219

9.  An in vitro pyrogen safety test for immune-stimulating components on surfaces.

Authors:  Marina Hasiwa; Karin Kullmann; Sonja von Aulock; Christoph Klein; Thomas Hartung
Journal:  Biomaterials       Date:  2006-12-08       Impact factor: 12.479

10.  Studies on the pathogenesis of fever with influenzal viruses. I. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus.

Authors:  E ATKINS; W C HUANG
Journal:  J Exp Med       Date:  1958-03-01       Impact factor: 14.307

View more
  2 in total

1.  Lipoteichoic acid, a cell wall component of Gram-positive bacteria, induces sleep and fever and suppresses feeding.

Authors:  Éva Szentirmai; Ashley R Massie; Levente Kapás
Journal:  Brain Behav Immun       Date:  2020-12-09       Impact factor: 7.217

2.  Application of a TLR overexpression cell model in pyrogen detection.

Authors:  Qing Han; Ruobi Hu; Hui Li; Zhen Lei; Xuehui Zhang; Xiuyan Yu; Qun Zhang; Yiqing Mao; Xi Wang; David M Irwin; Gang Niu; Huanran Tan
Journal:  Biotechnol Bioeng       Date:  2019-02-20       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.